Skip to content
PICO Portalanswers from OpenAlex

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations

PaperCitations, authors & open-access status

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is a paper indexed in PICO Portal from OpenAlex.

How many citations does Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations have?

PICO Portalcitation count

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations has 21 citations in the OpenAlex counts PICO Portal stores.

When was Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations published?

PICO Portalyear

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations has 2022 year in the PICO Portal index.

What is the open-access status of Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

PICO Portaloa status

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations has diamond oa status in the PICO Portal index.

What is the DOI of Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

PICO Portaldoi

The DOI for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is on the source record.

What is the PMID of Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

PICO Portalpmid

The PMID for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is on the source record.

What is the OpenAlex record for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

PICO Portalopenalex

The OpenAlex for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial